List of Excipients in API mavorixafor
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mavorixafor
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
X4 Pharmaceuticals Inc | XOLREMDI | mavorixafor | 83296-100 | CELLULOSE, MICROCRYSTALLINE | 2031-04-26 |
X4 Pharmaceuticals Inc | XOLREMDI | mavorixafor | 83296-100 | CROSCARMELLOSE SODIUM | 2031-04-26 |
X4 Pharmaceuticals Inc | XOLREMDI | mavorixafor | 83296-100 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | 2031-04-26 |
X4 Pharmaceuticals Inc | XOLREMDI | mavorixafor | 83296-100 | SILICON DIOXIDE | 2031-04-26 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for mavorixafor
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mavorixafor drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
mavorixafor drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
mavorixafor drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
mavorixafor drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
mavorixafor drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
mavorixafor drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
X4 Pharmaceuticals Inc | mavorixafor | 83296-100 |
>Company | >Ingredient | >NDC |
mavorixafor drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.